The Effects of Midazolam on the Quality of Postoperative Recovery

NCT01993459 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 192

Last updated 2016-01-26

No results posted yet for this study

Summary

The purpose of this study is to determine whether Midazolam given pre-operatively to patients undergoing abdominal surgery improves the quality of recovery.

Conditions

Interventions

DRUG

Midazolam

We will administer Midazolam 3mg intravenously once pre-operatively to patients just before they undergo surgery

DRUG

NaCl (sodium chloride) 0,9%

We will administer NaCl (sodium chloride) 0,9% 3ml intravenously once pre-operatively to patients just before they undergo surgery

Sponsors & Collaborators

Principal Investigators

  • Robert Jan Stolker, MD, PhD · Erasmus MC Rotterdam Anesthesiology

  • Markus Klimek, MD, PhD · Erasmus MC Rotterdam Anesthesiology

  • Stefan van Beek, BSc · Erasmus MC Rotterdam Anesthesiology

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-02-28
Primary Completion
2015-10-31
Completion
2015-10-31

Countries

  • Netherlands

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01993459 on ClinicalTrials.gov